EMEA (Europe, Middle East and Africa) Male Hypogonadism Market Report 2017
  • Published Date: 22-Aug-17 | Pages: 116
  • Single User: 4000 USD | Enterprice Wide License: 8000 USD

  • Description

    In this report, the EMEA Male Hypogonadism market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

    Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Male Hypogonadism for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

    EMEA Male Hypogonadism market competition by top manufacturers/players, with Male Hypogonadism sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Astrazeneca Plc.
    Merck & Co. Inc.
    Laboratories Genevrier
    Allergan Plc.
    Endo International Plc.
    Ferring
    AbbVie Inc.
    Eli Lilly and Company Ltd.
    Finox Biotech
    Teva Pharmaceutical Industries Ltd.
    Bayer AG
    IBSA Institut Biochimque

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Testosterone Replacement Therapy
    Gonadotropin-Releasing Hormones Therapy

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Male Hypogonadism for each application, including
    Kallmann Syndrome
    Klinefelters Syndrome
    Pituitary Disorders
    Others


    Research Methodology

    QY Reports in their recently published report, have emphasized upon the unique and key findings of the industry for a particular assessment period. The report mainly categorizes the custom market survey conducted by the experts to collect high-quality data analysis and visualization to bring out the various dynamics of the industry. It offers a detailed information about the latest updates such as several new technological advancements made, mergers and acquisitions, new entrants in the market, which make an impact on different segments of the industry.

    Segmental Analysis

    The global industry has been segmented on the basis of its products, regions, end users, technology, applications and cues for positioning, advertising & communication strategies. For a better understanding of the market, QY Reports has also provided a detailed analysis of drivers, restraints, and opportunities that dominate the present market scenario and also provides the anticipation of the future status of this industry.

    QY Reports emphasizes on the essentials of analyzing qualitative and quantitative aspects of the industry. While giving a brief idea about the revenue opportunities for all the segments, this report has also provided the impact of industry expertise to determine the scope of the study for all the segments over the predicted period.

    Regional Analysis

    The report comprises of the geographical landscape of the industry and is briefly segmented into key regions such as North America, the Asia Pacific, Latin America, and the Middle East and Africa. Our research methodology also focuses on understanding the niche countries such as Vietnam, Indonesia, Thailand, Malaysia, Mexico, and Italy to give lucid essence of the country-wide acceptance and growth of this industry. It also provides the reader with extensive data related to the market thus, empowering them to make informed decisions about doing business.

    Our infallible research methodology offers flexibility to suit varying budgets, deadlines, and altering market dynamics. Our researches cover a detailed comprehension of a wide spectrum of products and services, along with the business strategies adopted by the new entrants who are trying to establish themselves in the competitive landscape. The market size and revenue generated by each segments has been analyzed with the help of Basis Point Share technique, which accurately calculates the percentage change in the value of trending products.

    QY Reports is committed to offer a targeted market view in order to eliminate redundant information for the complete satisfaction of thereader.

    Various sales channels such as Original Equipment Manufacturers and aftermarkets across various key regions are covered in this report.

    Our quantitative research approach identifies the market size and how much it might be worth to find areas for sales growth. It also helps the reader understand the demographics of customers, such as their gender and age. The qualitative research renders a better understanding of the customer requirements and identifies opportunities for enhancing sales and also improving customer service.

    Our research experts have focused on to offer a detailed description of the supply side of the business before placing the product in the market. The syndicated research covers critical aspects of market research to generate useful strategies that ensure accurate analysis, high-level data integrity, and impeccable forecasts. On-demand customization or bespoke proposals are rendered to exactly meet the customer needs. The information provided regarding the geographical segmentation and the competitive landscape is based on the study done on the authenticated data from direct observations, online surveys, government agencies, industry bodies, and expert interviews.

    QY Reports offers market attractiveness, which presents a market index to help the clients and target audiences recognize the numerous opportunities that the industry holds.

    In order to authenticate the data, our experts have interviewed the industry experts on various panels across the globe who have sufficient experience and knowledge related to the field. QY Reports has used frameworks such as Year on Year growth forecast, parent market overview for data analysis, and the performance of various macroeconomic factors. Also, the analysts have gathered all the necessary information from the annual reports of various companies, their official websites, and some paid publications in order to offer full-proof reports to our clients.

    The report has developed a time-bound strategic roadmap for the readers by weaving different aspects of business into a winning fabric.


    Table of Contents

    EMEA (Europe, Middle East and Africa) Male Hypogonadism Market Report 2017
    1 Male Hypogonadism Overview
    1.1 Product Overview and Scope of Male Hypogonadism
    1.2 Classification of Male Hypogonadism
    1.2.1 EMEA Male Hypogonadism Market Size (Sales) Comparison by Type (2012-2022)
    1.2.2 EMEA Male Hypogonadism Market Size (Sales) Market Share by Type (Product Category) in 2016
    1.2.3 Testosterone Replacement Therapy
    1.2.4 Gonadotropin-Releasing Hormones Therapy
    1.3 EMEA Male Hypogonadism Market by Application/End Users
    1.3.1 EMEA Male Hypogonadism Sales (Volume) and Market Share Comparison by Application (2012-2022
    1.3.2 Kallmann Syndrome
    1.3.3 Klinefelters Syndrome
    1.3.4 Pituitary Disorders
    1.3.5 Others
    1.4 EMEA Male Hypogonadism Market by Region
    1.4.1 EMEA Male Hypogonadism Market Size (Value) Comparison by Region (2012-2022)
    1.4.2 Europe Status and Prospect (2012-2022)
    1.4.3 Middle East Status and Prospect (2012-2022)
    1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Male Hypogonadism (2012-2022)
    1.5.1 EMEA Male Hypogonadism Sales and Growth Rate (2012-2022)
    1.5.2 EMEA Male Hypogonadism Revenue and Growth Rate (2012-2022)

    2 EMEA Male Hypogonadism Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Male Hypogonadism Market Competition by Players/Manufacturers
    2.1.1 EMEA Male Hypogonadism Sales Volume and Market Share of Major Players (2012-2017)
    2.1.2 EMEA Male Hypogonadism Revenue and Share by Players (2012-2017)
    2.1.3 EMEA Male Hypogonadism Sale Price by Players (2012-2017)
    2.2 EMEA Male Hypogonadism (Volume and Value) by Type/Product Category
    2.2.1 EMEA Male Hypogonadism Sales and Market Share by Type (2012-2017)
    2.2.2 EMEA Male Hypogonadism Revenue and Market Share by Type (2012-2017)
    2.2.3 EMEA Male Hypogonadism Sale Price by Type (2012-2017)
    2.3 EMEA Male Hypogonadism (Volume) by Application
    2.4 EMEA Male Hypogonadism (Volume and Value) by Region
    2.4.1 EMEA Male Hypogonadism Sales and Market Share by Region (2012-2017)
    2.4.2 EMEA Male Hypogonadism Revenue and Market Share by Region (2012-2017)
    2.4.3 EMEA Male Hypogonadism Sales Price by Region (2012-2017)

    3 Europe Male Hypogonadism (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Male Hypogonadism Sales and Value (2012-2017)
    3.1.1 Europe Male Hypogonadism Sales Volume and Growth Rate (2012-2017)
    3.1.2 Europe Male Hypogonadism Revenue and Growth Rate (2012-2017)
    3.2 Europe Male Hypogonadism Sales and Market Share by Type
    3.3 Europe Male Hypogonadism Sales and Market Share by Application
    3.4 Europe Male Hypogonadism Sales Volume and Value (Revenue) by Countries
    3.4.1 Europe Male Hypogonadism Sales Volume by Countries (2012-2017)
    3.4.2 Europe Male Hypogonadism Revenue by Countries (2012-2017)
    3.4.3 Germany Male Hypogonadism Sales and Growth Rate (2012-2017)
    3.4.4 France Male Hypogonadism Sales and Growth Rate (2012-2017)
    3.4.5 UK Male Hypogonadism Sales and Growth Rate (2012-2017)
    3.4.6 Russia Male Hypogonadism Sales and Growth Rate (2012-2017)
    3.4.7 Italy Male Hypogonadism Sales and Growth Rate (2012-2017)
    3.4.8 Benelux Male Hypogonadism Sales and Growth Rate (2012-2017)

    4 Middle East Male Hypogonadism (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Male Hypogonadism Sales and Value (2012-2017)
    4.1.1 Middle East Male Hypogonadism Sales Volume and Growth Rate (2012-2017)
    4.1.2 Middle East Male Hypogonadism Revenue and Growth Rate (2012-2017)
    4.2 Middle East Male Hypogonadism Sales and Market Share by Type
    4.3 Middle East Male Hypogonadism Sales and Market Share by Application
    4.4 Middle East Male Hypogonadism Sales Volume and Value (Revenue) by Countries
    4.4.1 Middle East Male Hypogonadism Sales Volume by Countries (2012-2017)
    4.4.2 Middle East Male Hypogonadism Revenue by Countries (2012-2017)
    4.4.3 Saudi Arabia Male Hypogonadism Sales and Growth Rate (2012-2017)
    4.4.4 Israel Male Hypogonadism Sales and Growth Rate (2012-2017)
    4.4.5 UAE Male Hypogonadism Sales and Growth Rate (2012-2017)
    4.4.6 Iran Male Hypogonadism Sales and Growth Rate (2012-2017)

    5 Africa Male Hypogonadism (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Male Hypogonadism Sales and Value (2012-2017)
    5.1.1 Africa Male Hypogonadism Sales Volume and Growth Rate (2012-2017)
    5.1.2 Africa Male Hypogonadism Revenue and Growth Rate (2012-2017)
    5.2 Africa Male Hypogonadism Sales and Market Share by Type
    5.3 Africa Male Hypogonadism Sales and Market Share by Application
    5.4 Africa Male Hypogonadism Sales Volume and Value (Revenue) by Countries
    5.4.1 Africa Male Hypogonadism Sales Volume by Countries (2012-2017)
    5.4.2 Africa Male Hypogonadism Revenue by Countries (2012-2017)
    5.4.3 South Africa Male Hypogonadism Sales and Growth Rate (2012-2017)
    5.4.4 Nigeria Male Hypogonadism Sales and Growth Rate (2012-2017)
    5.4.5 Egypt Male Hypogonadism Sales and Growth Rate (2012-2017)
    5.4.6 Algeria Male Hypogonadism Sales and Growth Rate (2012-2017)

    6 EMEA Male Hypogonadism Manufacturers/Players Profiles and Sales Data
    6.1 Astrazeneca Plc.
    6.1.1 Company Basic Information, Manufacturing Base and Competitors
    6.1.2 Male Hypogonadism Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
    6.1.3 Astrazeneca Plc. Male Hypogonadism Sales, Revenue, Price and Gross Margin (2012-2017)
    6.1.4 Main Business/Business Overview
    6.2 Merck & Co. Inc.
    6.2.1 Company Basic Information, Manufacturing Base and Competitors
    6.2.2 Male Hypogonadism Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
    6.2.3 Merck & Co. Inc. Male Hypogonadism Sales, Revenue, Price and Gross Margin (2012-2017)
    6.2.4 Main Business/Business Overview
    6.3 Laboratories Genevrier
    6.3.1 Company Basic Information, Manufacturing Base and Competitors
    6.3.2 Male Hypogonadism Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
    6.3.3 Laboratories Genevrier Male Hypogonadism Sales, Revenue, Price and Gross Margin (2012-2017)
    6.3.4 Main Business/Business Overview
    6.4 Allergan Plc.
    6.4.1 Company Basic Information, Manufacturing Base and Competitors
    6.4.2 Male Hypogonadism Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
    6.4.3 Allergan Plc. Male Hypogonadism Sales, Revenue, Price and Gross Margin (2012-2017)
    6.4.4 Main Business/Business Overview
    6.5 Endo International Plc.
    6.5.1 Company Basic Information, Manufacturing Base and Competitors
    6.5.2 Male Hypogonadism Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
    6.5.3 Endo International Plc. Male Hypogonadism Sales, Revenue, Price and Gross Margin (2012-2017)
    6.5.4 Main Business/Business Overview
    6.6 Ferring
    6.6.1 Company Basic Information, Manufacturing Base and Competitors
    6.6.2 Male Hypogonadism Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
    6.6.3 Ferring Male Hypogonadism Sales, Revenue, Price and Gross Margin (2012-2017)
    6.6.4 Main Business/Business Overview
    6.7 AbbVie Inc.
    6.7.1 Company Basic Information, Manufacturing Base and Competitors
    6.7.2 Male Hypogonadism Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
    6.7.3 AbbVie Inc. Male Hypogonadism Sales, Revenue, Price and Gross Margin (2012-2017)
    6.7.4 Main Business/Business Overview
    6.8 Eli Lilly and Company Ltd.
    6.8.1 Company Basic Information, Manufacturing Base and Competitors
    6.8.2 Male Hypogonadism Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
    6.8.3 Eli Lilly and Company Ltd. Male Hypogonadism Sales, Revenue, Price and Gross Margin (2012-2017)
    6.8.4 Main Business/Business Overview
    6.9 Finox Biotech
    6.9.1 Company Basic Information, Manufacturing Base and Competitors
    6.9.2 Male Hypogonadism Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
    6.9.3 Finox Biotech Male Hypogonadism Sales, Revenue, Price and Gross Margin (2012-2017)
    6.9.4 Main Business/Business Overview
    6.10 Teva Pharmaceutical Industries Ltd.
    6.10.1 Company Basic Information, Manufacturing Base and Competitors
    6.10.2 Male Hypogonadism Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
    6.10.3 Teva Pharmaceutical Industries Ltd. Male Hypogonadism Sales, Revenue, Price and Gross Margin (2012-2017)
    6.10.4 Main Business/Business Overview
    6.11 Bayer AG
    6.12 IBSA Institut Biochimque

    7 Male Hypogonadism Manufacturing Cost Analysis
    7.1 Male Hypogonadism Key Raw Materials Analysis
    7.1.1 Key Raw Materials
    7.1.2 Price Trend of Key Raw Materials
    7.1.3 Key Suppliers of Raw Materials
    7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.2.1 Raw Materials
    7.2.2 Labor Cost
    7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Male Hypogonadism

    8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Male Hypogonadism Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Male Hypogonadism Major Manufacturers in 2016
    8.4 Downstream Buyers

    9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
    9.1.1 Direct Marketing
    9.1.2 Indirect Marketing
    9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
    9.2.1 Pricing Strategy
    9.2.2 Brand Strategy
    9.2.3 Target Client
    9.3 Distributors/Traders List

    10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
    10.1.1 Substitutes Threat
    10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

    11 EMEA Male Hypogonadism Market Forecast (2017-2022)
    11.1 EMEA Male Hypogonadism Sales, Revenue and Price Forecast (2017-2022)
    11.1.1 EMEA Male Hypogonadism Sales and Growth Rate Forecast (2017-2022)
    11.1.2 EMEA Male Hypogonadism Revenue and Growth Rate Forecast (2017-2022)
    11.1.3 EMEA Male Hypogonadism Price and Trend Forecast (2017-2022)
    11.2 EMEA Male Hypogonadism Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Male Hypogonadism Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Male Hypogonadism Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Male Hypogonadism Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Male Hypogonadism Sales Forecast by Type (2017-2022)
    11.7 EMEA Male Hypogonadism Sales Forecast by Application (2017-2022)

    12 Research Findings and Conclusion

    13 Appendix
    13.1 Methodology/Research Approach
    13.1.1 Research Programs/Design
    13.1.2 Market Size Estimation
    13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
    13.2.1 Secondary Sources
    13.2.2 Primary Sources
    13.3 Disclaimer